A Mixture of 3 Bifidobacteria Decreases Abdominal Pain and Improves the Quality of Life in Children with Irritable Bowel Syndrome

Journal of Clinical Gastroenterology

Volumn 51, Issue 1, 2017, Pages e5-e10

  Giannetti, Eleonora ^a   Maglione, Marco ^a   Alessandrella, Annalisa ^a   Strisciuglio, Caterina ^a,b   De Giovanni, Donatella ^c   Campanozzi, Angelo ^c   Miele, Erasmo ^a   Staiano, Annamaria ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c UNIVERSITY OF FOGGIA   (Italy)

Author keywords

abdominal pain; functional dyspepsia; irritable bowel syndrome; probiotics

Indexed keywords

AMYLASE; ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CALGRANULIN; HISTAMINE H2 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN A; PLACEBO; PROBIOTIC AGENT; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; PROTON PUMP INHIBITOR; TRIACYLGLYCEROL LIPASE;

ABDOMINAL PAIN; ADOLESCENT; ARTICLE; BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS; CHILD; CHILDHOOD DISEASE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFICACY; DYSPEPSIA; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SYMPTOM ASSESSMENT; BIFIDOBACTERIUM; CLINICAL TRIAL; COMPLICATION; DOUBLE BLIND PROCEDURE; MICROBIOLOGY; TREATMENT OUTCOME;

ABDOMINAL PAIN; ADOLESCENT; BIFIDOBACTERIUM; CHILD; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DYSPEPSIA; FEMALE; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; PROBIOTICS; QUALITY OF LIFE; SURVEYS AND QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 84974809080     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0000000000000528     Document Type: Article

References (41)

1. Chitkara DK, Rawat DJ, Talley NJ. The epidemiology of childhood recurrent abdominal pain in Western countries: A systematic review. Am J Gastroenterol. 2005;100:1868-1875.
2. Rasquin A, Di Lorenzo C, Forbes D, et al. Childhood functional gastrointestinal disorders: child/adolescent. Gastroenterology. 2006;130:1527-1537.
3. Hyams JS, Burke G, Davis PM, et al. Abdominal pain and irritable bowel syndrome in adolescents: A community-based study. J Pediatr. 1996;129:220-226.
4. Andrews EB, Eaton SC, Hollis KA, et al. Prevalence and demographics of irritable bowel syndrome: results from a large web-based survey. Aliment Pharmacol Ther. 2005;22:935-942.
5. Chang L. Review article: epidemiology and quality of life in functional gastrointestinal disorders. Aliment Pharmacol Ther. 2004;20(suppl 7):31-39.
6. Mayer EA, Tillisch K. The brain-gut axis in abdominal pain syndromes. Annu Rev Med. 2011;62:381-396.
7. Simrén M, Barbara G, Flint HJ, et al. Intestinal microbiota in functional bowel disorders: A Rome foundation report. Gut. 2013;62:159-176.
8. De Palma G, Collins SM, Bercik P. The microbiota-gut brain axis in functional gastrointestinal disorders. Gut Microbes. 2014;5:419-429.
9. Cuomo R, Savarese MF, Gargano R. Almost all irritable bowel syndromes are post-infectious and respond to probiotics: consensus issues. Dig Dis. 2007;25:241-244.
10. Wilhelm SM, Brubaker CM, Varcak EA, et al. Effectiveness of probiotics in the treatment of irritable bowel syndrome. Pharmacotherapy. 2008;28:496-505.
11. Enck P, Zimmermann K, Menke G, et al. A mixture of Escherichia coli (DSM 17252) and Enterococcus faecalis (DSM 16440) for treatment of the irritable bowel syndrome-a randomized controlled trial with primary care physicians. Neurogastroenterol Motil. 2008;20:1103-1109.
12. Brenner DM, Moeller MJ, Chey WD, et al. The utility of probiotics in the treatment of irritable bowel syndrome: A systematic review. Am J Gastroenterol. 2009;104:1033-1049.
13. Moayyedi P, Ford AC, Talley NJ, et al. The efficacy of probiotics in the therapy of irritable bowel syndrome: A systematic review. Gut. 2010;59:325-332.
14. Hoveyda N, Heneghan C, Mahtani KR, et al. A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome. BMC Gastroenterol. 2009;9:15.
15. McFarland LV, Dublin S. Meta-analysis of probiotics for the treatment of irritable bowel syndrome. World J Gastroenterol. 2008;14:2650-2661.
16. Nikfar S, Rahimi R, Rahimi F, et al. Efficacy of probiotics in irritable bowel syndrome: A meta-analysis of randomized, controlled trials. Dis Colon Rectum. 2008;51:1775-1780.
17. Horvath A, Dziechciarz P, Szajewska H. Meta-analysis: Lactobacillus rhamnosus GG for abdominal pain-related functional gastrointestinal disorders in childhood. Aliment Pharmacol Ther. 2011;33:1302-1310.
18. Guandalini S, Magazzù G, Chiaro A, et al. VSL#3 improves symptoms in children with irritable bowel syndrome: A multicenter, randomized, placebo-controlled, double-blind, crossover study. J Pediatr Gastroenterol Nutr. 2010;51:24-30.
19. Gawronska A, Dziechciarz P, Horvath A, et al. A randomized double-blind placebo-controlled trial of Lactobacillus GG for abdominal pain disorders in children. Aliment Pharmacol Ther. 2007;25:177-184.
20. Di Gioia D, Aloisio I, Mazzola G, et al. Bifidobacteria: their impact on gut microbiota composition and their applications as probiotics in infants. Appl Microbiol Biotechnol. 2014;98: 563-577.
21. Walker LS, Caplan A, Rasquin A. Questionnaire on Pediatric Gastrointestinal Symptoms, Rome III Version (QPGS-RIII). In: Drossman DA, Corazziari E, Delvaux N, Spiller RC, Talley NJ, Thompson WG, eds. Rome III: The Functional Gastrointestinal Disorders, 3rd ed. McLean, VA: Degnon Associates; 2006:961-990.
22. Claar RL, Walker LS. Functional assessment of pediatric pain patients: psychometric properties of the functional disability inventory. Pain. 2006;121:77-84.
23. Di Lorenzo C, Colletti RB, Lehmann HP, et alAAP Subcommittee. NASPGHAN Committee on Chronic Abdominal Pain. Chronic abdominal pain in children: A technical report of the American Academy of Pediatrics and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2005;40:249-261.
24. Levy RL, Olden KW, Naliboff BD, et al. Psychosocial aspects of the functional gastrointestinal disorders. Gastroenterology. 2006;130:1447-1458.
25. Howell S, Poulton R, Talley NJ. The natural history of childhood abdominal pain and its association with adult irritable bowel syndrome: birth-cohort study. Am J Gastroenterol. 2005;100:2071-2078.
26. Koloski NA, Talley NJ, Boyce PM. Epidemiology and health care seeking in the functional GI disorders: A population-based study. Am J Gastroenterol. 2002;97:2290-2299.
27. Mayer EA. Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci. 2011;12:453-466.
28. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006;130:1377-1390.
29. Gibson PR, Shepherd SJ. Food choice as a key management strategy for functional gastrointestinal symptoms. Am J Gastroenterol. 2012;107:657-666. Quiz 667.
30. Eccleston C, Palermo TM, de C Williams AC, et al. Psychological therapies for the management of chronic and recurrent pain in children and adolescents. Cochrane Database Syst Rev. 2012:12CD003968.
31. Guandalini S. Are probiotics or prebiotics useful in pediatric irritable bowel syndrome or inflammatory bowel disease? Front Med (Lausanne). 2014;1:23.
32. Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. 2012;13:701-712.
33. Bravo JA, Forsythe P, Chew MV, et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci USA. 2011;108:16050-16055.
34. Carabotti M, Scirocco A, Maselli MA, et al. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol. 2015;28:203-209.
35. O'Mahony L, McCarthy J, Kelly P, et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology. 2005;128:541-551.
36. Kim HJ, Vazquez Roque MI, Camilleri M, et al. A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating. Neurogastroenterol Motil. 2005;17:687-696.
37. Kajander K, Myllyluoma E, Rajilic-Stojanovic M, et al. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota. Aliment Pharmacol Ther. 2008;27:48-57.
38. Bauserman M, Michail S. The use of Lactobacillus GG in irritable bowel syndrome in children: A double-blind randomized control trial. J Pediatr. 2005;147:197-201.
39. Patel SM, Stason WB, Legedza A, et al. The placebo effect in irritable bowel syndrome trials: A meta-analysis. Neurogastroenterol Motil. 2005;17:332-340.
40. Kashikar-Zuck S, Flowers SR, Claar RL, et al. Clinical utility and validity of the Functional Disability Inventory among a multicenter sample of youth with chronic pain. Pain. 2011;152:1600-1607.
41. Whorwell PJ, Altringer L, Morel J, et al. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol. 2006;101:1581-1590.